CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

888 results.
Study Number Lead Group Study Title CIRB Study Status
ABTC-1701 ABTC Pilot Surgical PK Study of BGB324 in Recurrent Glioblastoma Patients Adult CIRB - Early Phase Emphasis Available to Open
ABTC-1804 ABTC Determining the Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients with Gliomas Adult CIRB - Late Phase Emphasis Available to Open
CITN-14 CITN A Randomized Phase II Study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma Adult CIRB - Early Phase Emphasis Available to Open
PED-CITN-03 Pediatric CITN Phase 1 Trial of Hu5F9-G4 (Magrolimab) Combined with Dinutuximab in Children and Young Adults with Relapsed and Refractory Neuroblastoma or Relapsed Osteosarcoma Pediatric CIRB Available to Open
PED-CITN-01 Pediatric CITN 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Pediatric CIRB Available to Open
PEPN1812 PEP-CTN A Phase 1 Trial of the CD123 X CD3 DART® Molecule Flotetuzumab (NSC#808294, IND#145986) in Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia Pediatric CIRB Available to Open
PEPN1924 PEP-CTN A Phase 2 Study of DS-8201A (NSC# 807708, IND# TBD) in Adolescents, or Young Adults with Recurrent HER2+ Osteosarcoma Pediatric CIRB Available to Open
AMC-107 AMC A Phase 2 Trial of Ixazomib for Kaposi Sarcoma Adult CIRB - Late Phase Emphasis Available to Open
888 results.